METTL3 drives tumorigenesis and lung/lymph node metastasis in gastric cancer via the PBX1/GCH1 axis, elevating tetrahydrobiopterin levels to enhance metastatic aggressiveness [196]. Here, METTL3 is linked to gastric cancer.